生物活性 | |||
---|---|---|---|
描述 | VUF11207 fumarate is a CXCR7 agonist that binds specifically to CXCR7. At a concentration of 0.17 nM for 5 days, VUF11207 fumarate inhibits RANKL- and TNF-α-induced osteoclastogenesis by inhibiting CXCL12 in osteoclast precursor cells and inhibits the phosphorylation of ERK[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.70mL 0.34mL 0.17mL |
8.52mL 1.70mL 0.85mL |
17.05mL 3.41mL 1.70mL |
参考文献 |
---|